Ultragenyx Pharmaceutical Inc. - Insider Trading & Ownership
Location
60 Leveroni Court, Novato, CA
Summary
The estimated value of insider holdings of Ultragenyx Pharmaceutical Inc. is at least $26.2M dollars as of August 12, 2021. Ultragenyx Pharmaceutical Inc. is the Director of Arcturus Therapeutics Holdings Inc. and owns shares of Arcturus Therapeutics Holdings Inc. (ARCT) stock worth about $26.2M.
Signature
/s/ Mardi C. Dier, EVP and Chief Financial Officer
Insider Transactions Reported by Ultragenyx Pharmaceutical Inc.:
Sym
Company
Class
Transaction
%
Value $
* Price $
Shares
Shares After
Date
Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.